December 2024's Top Penny Stocks To Keep An Eye On

In This Article:

As global markets grapple with cautious Federal Reserve commentary and political uncertainty, investors are navigating a complex landscape marked by interest rate adjustments and economic growth fluctuations. Amid these broader market dynamics, penny stocks remain an intriguing area for potential investment. Despite their somewhat outdated name, these stocks often represent smaller or newer companies that can offer significant opportunities for growth when backed by strong financials and sound fundamentals.

Top 10 Penny Stocks

Name

Share Price

Market Cap

Financial Health Rating

DXN Holdings Bhd (KLSE:DXN)

MYR0.51

MYR2.54B

★★★★★★

Embark Early Education (ASX:EVO)

A$0.765

A$140.36M

★★★★☆☆

Datasonic Group Berhad (KLSE:DSONIC)

MYR0.41

MYR1.14B

★★★★★★

Hil Industries Berhad (KLSE:HIL)

MYR0.89

MYR295.43M

★★★★★★

MGB Berhad (KLSE:MGB)

MYR0.74

MYR437.82M

★★★★★★

Bosideng International Holdings (SEHK:3998)

HK$4.14

HK$45.59B

★★★★★★

LaserBond (ASX:LBL)

A$0.55

A$64.47M

★★★★★★

Begbies Traynor Group (AIM:BEG)

£0.926

£146.07M

★★★★★★

Lever Style (SEHK:1346)

HK$0.86

HK$545.92M

★★★★★★

Secure Trust Bank (LSE:STB)

£3.52

£67.13M

★★★★☆☆

Click here to see the full list of 5,841 stocks from our Penny Stocks screener.

We're going to check out a few of the best picks from our screener tool.

Amanat Holdings PJSC

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Amanat Holdings PJSC, with a market cap of AED2.70 billion, invests in companies and enterprises within the education and healthcare sectors through its subsidiaries.

Operations: The company generates revenue from two primary segments: Education, contributing AED395.21 million, and Healthcare, contributing AED394.11 million.

Market Cap: AED2.7B

Amanat Holdings PJSC, with a market cap of AED2.70 billion, operates in the education and healthcare sectors. Despite generating significant revenue from both segments—AED395.21 million in Education and AED394.11 million in Healthcare—the company remains unprofitable, with losses increasing at 13.9% annually over the past five years. The recent earnings report shows a net loss of AED11.11 million for Q3 2024, despite an increase in sales to AED132.86 million compared to last year’s figures. While Amanat has more cash than debt and covers interest payments adequately, its dividend is not well-supported by earnings or cash flows.

DFM:AMANAT Revenue & Expenses Breakdown as at Dec 2024
DFM:AMANAT Revenue & Expenses Breakdown as at Dec 2024

Dubai Investments PJSC

Simply Wall St Financial Health Rating: ★★★★★☆